House Of Lords To Hear Amgen,TKT Patent Dispute Next Week

Law360, New York (July 2, 2004, 12:00 AM EDT) -- England’s highest court, the House of Lords, will hear the long-running patent dispute between Amgen and Transkaryotic Therapies/Hoechst over the blockbuster blood booster hormone erythropoietin (epo) next week.

The case, which is the first biotech case in eight years to be heard by the court, will open on Monday 5 and is set to run for 2 weeks.

House of Lords judgments are usually handed down within 6 to 8 working weeks. The Lords will be closed for their long summer vacation over the whole of...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.